Nuclear Medicine and Biology
Volume 35, Issue 8 , Pages 839-849, November 2008

Optimised labeling, preclinical and initial clinical aspects of CCK-2 receptor-targeting with 3 radiolabeled peptides

  • Wouter A.P. Breeman

      Affiliations

    • Department of Nuclear Medicine, Erasmus MC Rotterdam's 3015 CE Rotterdam, The Netherlands
    • Corresponding Author InformationCorresponding author. Tel.: +31 10 7035317.
  • ,
  • A.C. Fröberg

      Affiliations

    • Department of Nuclear Medicine, Erasmus MC Rotterdam's 3015 CE Rotterdam, The Netherlands
  • ,
  • E. de Blois

      Affiliations

    • Department of Nuclear Medicine, Erasmus MC Rotterdam's 3015 CE Rotterdam, The Netherlands
  • ,
  • A. van Gameren

      Affiliations

    • Department of Nuclear Medicine, Erasmus MC Rotterdam's 3015 CE Rotterdam, The Netherlands
  • ,
  • M. Melis

      Affiliations

    • Department of Nuclear Medicine, Erasmus MC Rotterdam's 3015 CE Rotterdam, The Netherlands
  • ,
  • M. de Jong

      Affiliations

    • Department of Nuclear Medicine, Erasmus MC Rotterdam's 3015 CE Rotterdam, The Netherlands
  • ,
  • T. Maina

      Affiliations

    • Molecular Radiopharmacy Section, I/R-RP, NCSR “Demokritos”, Athens, Greece
  • ,
  • B.A. Nock

      Affiliations

    • Molecular Radiopharmacy Section, I/R-RP, NCSR “Demokritos”, Athens, Greece
  • ,
  • J.L. Erion

      Affiliations

    • BioSynthema Inc., St. Louis, MO, USA
  • ,
  • H.R. Mäcke

      Affiliations

    • Radiological Chemistry, University Hospital Basel, Switzerland
  • ,
  • E.P. Krenning

      Affiliations

    • Department of Nuclear Medicine, Erasmus MC Rotterdam's 3015 CE Rotterdam, The Netherlands
    • Department of Internal Medicine, Erasmus MC, Rotterdam, The Netherlands

Received 15 August 2008; received in revised form 19 September 2008; accepted 28 September 2008.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S0969-8051(08)00199-6

doi:10.1016/j.nucmedbio.2008.09.006

Nuclear Medicine and Biology
Volume 35, Issue 8 , Pages 839-849, November 2008